WHITEHOUSE STATION, N.J. -- Supermarkets can expect Merck & Company's new prescription drug Vioxx, a "super-aspirin" alternative to conventional pain killers, to be available at their pharmacy counters later this month. the first in a new class of drugs called COX-2 inhibitors to battle pain and inflammation without the harsh side effects of aspirin and related drugs like ibuprophen, which can cause deadly internal bleeding. Merck, which announced Food and Drug Administration approval ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.